Although Costa Rica has no explicit constitutional right to health, its constitutional chamber of the Supreme Court (Sala IV) has become increasingly central to the resolution of many health care decisions. Some argue that courts’ decisions about individuals’ access to very expensive medications could upset the country’s medical priorities and harm the state’s general health care provision capacity. This article assesses whether health rights litigation concerning the right to medications leads to more fairness in access to medications in Costa Rica. We review randomly selected access to medicines cases successfully claimed at the Sala IV in 2008 and classify them into four priority groups using standard priority-setting criteria. We find that 2.7% of the successful cases fall into priority group I (highest priority), 27% in group II, 48.6% in group III, and 21.6% in group IV (experimental treatment). Our analysis reveals a majority of successful health rights litigation for medications results in court-mandated provision of new, expensive drugs, many with only marginal benefits. More than 70% of the successful cases evaluated concerned medications judged to be of low priority. Based on these cases, we cannot conclude that litigation leads to more fairness in access to medications.
“Satanism is witchcraft’s younger sibling”: Changing perceptions of natural and supernatural anaemia causality in Malawian children
Sarah Svege, Thandile Nkosi-Gondwe, Siri Lange
Prevalence, risk factors and association with delivery outcome of curable sexually transmitted infections among pregnant women in Southern Ethiopia
Mengistu Hailemariam Zenebe, Zeleke Mekonnen, Eskindir Loha, Elizaveta Padalko
Pay-for-performance reduces bypassing of health facilities: evidence from Tanzania
Sosina Bezu Chiksa, Peter John Binyaruka, Ottar Mæstad, Vincent Somville
Social Science and Medicine